Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Shanghai Research Center for Modernization of Traditional Chinese Medicine (SRCMTCM) is a prominent research and development institution focused on the scientific validation and standardization of Traditional Chinese Medicine (TCM). Established in 2000 through a partnership between the Chinese Academy of Sciences, the Ministry of Science and Technology, and the Shanghai Municipal Government, the center bridges the gap between ancient herbal wisdom and modern pharmaceutical science. Its core capabilities include the discovery of bioactive compounds, the development of international quality standards, and the creation of innovative TCM-based drug candidates. SRCMTCM operates advanced platforms for TCM fingerprinting and high-throughput screening, facilitating the global commercialization of evidence-based natural products. The center serves as a critical hub for academic-industrial collaboration, driving the modernization of TCM for cardiovascular, metabolic, and neurological indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Research Center for Modernization of Traditional Chinese Medicine.